Related Experiment Video
Updated: Aug 12, 2026
11:58
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Transferrin receptors in the parkinsonian midbrain
C M Morris1, J M Candy, S Omar
1MRC Neurochemical Pathology Unit, Newcastle General Hospital, Newcastle upon Tyne, UK.
Neuropathology and Applied Neurobiology
|October 1, 1994
Summary
Parkinson's disease (PD) may involve iron regulation issues. Researchers found reduced transferrin receptor binding in specific brain areas of PD patients, suggesting compensatory iron uptake in remaining neurons.
Area of Science:
- Neuroscience
- Neurodegenerative Diseases
- Iron Metabolism
Background:
- Parkinson's disease (PD) pathogenesis is multifactorial.
- Altered iron homeostasis is a potential contributing factor in PD.
- The transferrin receptor is crucial for cellular iron uptake.
Purpose of the Study:
- To investigate the distribution and density of transferrin receptors in the midbrain of normal and PD subjects.
- To assess the role of transferrin receptor expression in Parkinson's disease.
Main Methods:
- Utilized [3H]-transferrin ([3H]-Tf) binding assays.
- Employed tritium film autoradiography for spatial analysis.
- Examined midbrain tissue from both normal and Parkinson's disease individuals.
Main Results:
- High [3H]-Tf binding observed in the dorsal raphe, oculomotor nucleus, and periaqueductal gray.
- Lower [3H]-Tf binding detected in the tegmentum, red nucleus, and substantia nigra.
- Significant reductions in [3H]-Tf binding were found in the substantia nigra, red nucleus, and oculomotor nucleus in PD patients, correlating with neuronal loss.
Conclusions:
- The study indicates reduced transferrin receptor binding in specific midbrain regions in Parkinson's disease.
- Observed reductions in binding correlate with the loss of neurons in PD.
- Increased iron in surviving neurons may represent a compensatory mechanism, not aberrant receptor expression.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:28The Early Endosome: Endocytosis of Transferrin
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...